Elagolix treatment in women with heavy menstrual bleeding-associated with uterine fibroids: Efficacy and safety results from a phase 2b study

JA Simon, EA Stewart, C Owens, WR Duan, J Gao… - Fertility and …, 2017 - fertstert.org
Objective Elagolix is an oral, non-peptide, gonadotropin-releasing hormone antagonist.
Elagolix was evaluated in premenopausal women with heavy menstrual bleeding (HMB;> …
被引用次数：4 相关文章

Elagolix Treatment in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids: Efficacy and Safety Results From a Phase 2B Study

JA Simon, EA Stewart, K Chwalisz, WR Duan… - Journal of Minimally …, 2017 - jmig.org
Study Objective: To evaluate safety and efficacy of elagolix, an oral, non-peptide,
gonadotropin-releasing hormone antagonist, with/without add-back therapy in women with …